FDA Recommends Further Limiting Use Of Laparoscopic Power Morcellation
Executive Summary
The US FDA is updating its labeling guidance on laparoscopic power morcellation to reflect new evidence showing the treatment may pose a higher cancer risk in older women, as well as to add discussion of containment systems.